// App-Quantinova.ai

3859 : Peptidomimetic Src kinase inhibitor KX-01 sensitizes estrogen receptor -negative breast tumor xenografts to tamoxifen by inducing ER re-expression

Researchers

Presenter

  • Murali Anbalagan

Principal Investigators

  • Mei Sheng

  • Brian Fleischer

  • David Hangauer

  • Brian G. Rowan

Medical Centers

  • Tulane University School of Medicine, New Orleans, LA

  • Athenex, Buffalo, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Triple-negative breast cancer

  • Breast cancer

  • Solid malignancies

Biomarkers

  • Cadherin 1

  • Progesterone receptor

  • cMYC

  • erb-b2 receptor tyrosine kinase 2

  • DNA methylation

Drug/Treatment

  • Alora

  • Tamoxifen

  • KX-01

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved